S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
The single greatest medical breakthrough of all time? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Why Turkey's currency is crashing after Erdogan got reelected
The single greatest medical breakthrough of all time? (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
The single greatest medical breakthrough of all time? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
The single greatest medical breakthrough of all time? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Why Turkey's currency is crashing after Erdogan got reelected
The single greatest medical breakthrough of all time? (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
The single greatest medical breakthrough of all time? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
The single greatest medical breakthrough of all time? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Why Turkey's currency is crashing after Erdogan got reelected
The single greatest medical breakthrough of all time? (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
The single greatest medical breakthrough of all time? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
The single greatest medical breakthrough of all time? (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Why Turkey's currency is crashing after Erdogan got reelected
The single greatest medical breakthrough of all time? (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
The single greatest medical breakthrough of all time? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
OTCMKTS:CLPBY

Coloplast A/S (CLPBY) Stock Forecast, Price & News

$12.40
-0.06 (-0.48%)
(As of 06/9/2023 ET)
Compare
Today's Range
$12.36
$12.51
50-Day Range
$12.40
$14.65
52-Week Range
$9.58
$14.77
Volume
25,741 shs
Average Volume
46,757 shs
Market Capitalization
$26.78 billion
P/E Ratio
44.29
Dividend Yield
0.62%
Price Target
N/A

Coloplast A/S MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
12.50%
From $0.32 to $0.36 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.24 out of 5 stars


CLPBY stock logo

About Coloplast A/S (OTCMKTS:CLPBY) Stock

Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.

Receive CLPBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter.

CLPBY Stock News Headlines

Brokerages Set Coloplast A/S (OTCMKTS:CLPBY) PT at $942.50
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
CLPBY Coloplast A/S
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Short Volatility Alert: Coloplast
Coloplast Launches New Catheter in the U.S.
Coloplast A/S
See More Headlines

CLPBY Price History

CLPBY Company Calendar

Last Earnings
5/02/2019
Ex-Dividend for 5/30 Dividend
5/19/2023
Dividend Payable
5/30/2023
Today
6/10/2023

Industry, Sector and Symbol

Industry
Surgical Appliances & Supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CLPBY
Previous Symbol
NASDAQ:CLPBY
Fax
N/A
Employees
12,500
Year Founded
1954

Profitability

Net Income
$585.21 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.76 billion
Cash Flow
$0.24 per share
Book Value
$0.48 per share

Miscellaneous

Outstanding Shares
2,160,000,000
Free Float
N/A
Market Cap
$26.78 billion
Optionable
Not Optionable
Beta
0.28

Social Links


Key Executives

  • Kristian Villumsen
    President & Chief Executive Officer
  • Allan Rasmussen
    Executive Vice President-Global Operations
  • Anders Lonning-Skovgaard
    Chief Financial Officer & Executive Vice President
  • Thomas Barfod
    Director & Controller
  • Paul Marcun
    Executive Vice President-Growth













CLPBY Stock - Frequently Asked Questions

Should I buy or sell Coloplast A/S stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Coloplast A/S in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CLPBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLPBY, but not buy additional shares or sell existing shares.
View CLPBY analyst ratings
or view top-rated stocks.

How have CLPBY shares performed in 2023?

Coloplast A/S's stock was trading at $11.63 at the beginning of 2023. Since then, CLPBY shares have increased by 6.6% and is now trading at $12.40.
View the best growth stocks for 2023 here
.

Are investors shorting Coloplast A/S?

Coloplast A/S saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 2,300 shares, a decline of 87.1% from the April 30th total of 17,800 shares. Based on an average daily volume of 55,300 shares, the days-to-cover ratio is presently 0.0 days.
View Coloplast A/S's Short Interest
.

How were Coloplast A/S's earnings last quarter?

Coloplast A/S (OTCMKTS:CLPBY) released its quarterly earnings data on Thursday, May, 2nd. The company reported $0.07 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.07. The business had revenue of $688.45 million for the quarter. Coloplast A/S had a trailing twelve-month return on equity of 69.30% and a net margin of 21.62%.

How often does Coloplast A/S pay dividends? What is the dividend yield for Coloplast A/S?

Coloplast A/S announced a dividend on Wednesday, May 17th. Shareholders of record on Monday, May 22nd will be paid a dividend of $0.0475 per share on Tuesday, May 30th. This represents a yield of 1.34%. The ex-dividend date of this dividend is Friday, May 19th.
Read our dividend analysis for CLPBY
.

Is Coloplast A/S a good dividend stock?

Coloplast A/S (OTCMKTS:CLPBY) pays an annual dividend of $0.08 per share and currently has a dividend yield of 1.40%. The dividend payout ratio is 27.50%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLPBY will have a dividend payout ratio of 21.39% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLPBY.

What is Coloplast A/S's stock symbol?

Coloplast A/S trades on the OTCMKTS under the ticker symbol "CLPBY."

How do I buy shares of Coloplast A/S?

Shares of CLPBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Coloplast A/S's stock price today?

One share of CLPBY stock can currently be purchased for approximately $12.40.

How much money does Coloplast A/S make?

Coloplast A/S (OTCMKTS:CLPBY) has a market capitalization of $26.78 billion and generates $2.76 billion in revenue each year. The company earns $585.21 million in net income (profit) each year or $0.28 on an earnings per share basis.

How many employees does Coloplast A/S have?

The company employs 12,500 workers across the globe.

How can I contact Coloplast A/S?

Coloplast A/S's mailing address is HOLTEDAM 1-3, HUMLEBAEK G7, 3050. The official website for the company is www.coloplast.com. The company can be reached via phone at (454) 911-1111 or via email at dkebj@coloplast.com.

This page (OTCMKTS:CLPBY) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -